USE OF IMMUNOSUPPRESSIVE AGENTS FOR THE TREATMENT OF SCHIZOPHRENIA
摘要
<p>The invention relates to a pharmaceutical composition for the treatment of schizophrenic disorders which comprises a pharmaceutically acceptable carrier and as active ingredient an immunosuppressive agent.</p>
